January 4, 2017 / 6:39 AM / a year ago

France to suspend sales of Uvesterol D Vitamin D deficiency product

PARIS, Jan 4 (Reuters) - France has started measures to suspend sales of a product known as Uvesterol D, used for Vitamin D deficiency, after the death of a baby who had been given a dose of it, a French medical safety watchdog said on Wednesday.

“The conclusions of investigations so far show evidence pointing to a probable link between the death, and the dose of Uvesterol D that was administered,” the medical safety agency ANSM said in a statement.

Uvesterol D is developed by the Crinex laboratory.

Officials at Crinex could not be immediately reached for comment.

Reporting by Sudip Kar-Gupta and Eric Faye; Editing by Robert Birsel

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below